| tüüp : |
ajaleht |
| interneti link : |
https://doi.org/10.1016/S0887-8994(98)00134-9 |
|
| uurimisrühmad : |
Columbus - The Ohio State University Hospitals, Department of Pharmacy |
| Autor : |
Nahata MC. |
| pealkiri : |
Development of two stable oral suspensions of gabapentin. |
| publikatsioon : |
Pediatr Neurol ; 20: 195-197. 1999 |
|
| Tõendite tase : |
|
| füüsikaline stabiilsus : |
|
| Keemiline püsivus : |
|
| Muud meetodid : |
|
| Kommentaarid : |
|
ingredientide nimekiri
 Gabapentine
|
 |
 |
 |
|
3000 mg
Neurontin® |
| Lihtsiirup / Metüültselluloos 1% (1:1) |
>> 30 ml |
|
25°C |
 |
| 56 |
 |
|
|
|
|
|
3000 mg
Neurontin® |
| OraPlus® / OraSweet® (1:1) |
>> 30 ml |
|
25°C |
|
| 56 |
|
|
|
|
|
|
3000 mg
Neurontin® |
| Lihtsiirup / Metüültselluloos 1% (1:1) |
>> 30 ml |
|
4°C |
|
| 91 |
|
|
|
|
|
|
3000 mg
Neurontin® |
| OraPlus® / OraSweet® (1:1) |
>> 30 ml |
|
4°C |
|
| 56 |
|
|
|
|
|
